List of all news

17. 2. 2017
...continue

Trade Mission to Central Asia countries

Representatives of IMCoPharma joined the business mission (February 5-11, 2017) in the Central Asian countries (Kazakhstan, Uzbekistan, Tajikistan), during which there were also

...continue

9. 2. 2017
...continue

Meet us at GEP-Kiev Conference

On the 1st and 2nd of March 2017 IMCoPharma is going to take part in the conference GEP-Kiev 2017 alongside with Favea Group, the main organizer of this event. The topic of

...continue

19. 1. 2017
...continue

New pharmaceutical substance Ropivacaine HCl (API) available in Russia

The inclusion in the State Register of Medicinal Remedies of Russian Federation of the pharmaceutical substance Ropivacaine HCl (API), produced by the company Excella GmbH &

...continue

17. 1. 2017
...continue

Video from the venue Pharmtech & Ingredients 2016

Watch a short video from the venue Pharmtech & Ingredients 2016 and the interview with the Commercial Director, Mr. Lukas Adamec, speaking on the subject of main activities of

...continue

9. 1. 2017
...continue

F.I.S. acquisition of Zach-Lonigo chemical plant

F.I.S. – Fabbrica Italiana Sintetici, a leading pharmaceutical manufacturer of APIs, acquired Zach chemical site located in Lonigo (Vicenza, Italy), which is working in the field

...continue

19. 12. 2016
...continue

IMCoPharma awarded at competition «Exporter of the year 2016»

IMCoPharma has won the 3rd place in the annual competition «Exporter of the year 2016» of the medium-sized business award category – Export increase in 2014-2015.The 22nd

...continue

2. 12. 2016
...continue

IMCoPharma´s presence at Pharmtech & Ingredients 2016

IMCoPharma participated at Pharmtech & Ingredients. The four days exhibition was held in Moscow (Russia) from 22-25 November 2016.Our presence at the fair helped us to support

...continue

30. 11. 2016
...continue

New pharmaceutical substance Capecitabine available in Russia

The inclusion in the State Register of Medicinal Remedies of Russian Federation of the pharmaceutical substance Capecitabine produced by the company Excella GmbH & Co. KG,

...continue

4. 11. 2016
...continue

New oncological substance Temozolomide available in Russia

The inclusion in the State Register of Medicinal Products of the Russian Federation of the pharmaceutical substance Temozolomide produced by the company Excella GmbH & Co. KG,

...continue

27. 10. 2016
...continue

IMCoPharma received a financial grant

The company IMCoPharma has got a grant from the budget of the Moravian-Silesian Region in the grant programme "Support of Entrepreneurship in the Moravian-Silesian Region

...continue

21. 10. 2016
...continue

Pharmtech&Ingrediends 2016 in Moscow – Visit our stand no. A107

On 22-25 November 2016 our company IMCoPharma is going to take part in the event Pharmtech&Ingrediends 2016, currently the largest international exhibition in Russia and the

...continue

20. 10. 2016
...continue

IMCoPharma´s presence at CPhI Worldwide 2016

On 4 – 6 October 2016 our company IMCoPharma participated as an exhibitor at CPhI Worldwide 2016 in Barcelona (Spain), the world's leading European pharmaceutical exhibition. At

...continue

Use an opportunity to meet us:

Kiev, Ukraine<br />
1st-2nd March 2017<br />
Premier Hotel Rus

Kiev, Ukraine
1st-2nd March 2017
Premier Hotel Rus

Moscow, Russia<br />
28th - 30th March 2017<br />
Stand no.: 500/hall 75 A

Moscow, Russia
28th - 30th March 2017
Stand no.: 500/hall 75 A

Frankfurt,  Germany<br />
24th - 26th October 2017<br />
Stand no.: 4.0B42

Frankfurt, Germany
24th - 26th October 2017
Stand no.: 4.0B42

version dated 26.2.2017, time 04:10